Horizon Investments LLC Has $681,000 Stock Holdings in Kenvue Inc. $KVUE

Horizon Investments LLC grew its stake in shares of Kenvue Inc. (NYSE:KVUE) by 5.5% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 28,406 shares of the company’s stock after purchasing an additional 1,489 shares during the quarter. Horizon Investments LLC’s holdings in Kenvue were worth $681,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Providence Capital Advisors LLC boosted its holdings in shares of Kenvue by 2.8% in the 1st quarter. Providence Capital Advisors LLC now owns 123,072 shares of the company’s stock valued at $2,951,000 after buying an additional 3,328 shares during the last quarter. Trivium Point Advisory LLC bought a new stake in Kenvue during the first quarter worth $201,000. Vestmark Advisory Solutions Inc. raised its position in Kenvue by 119.5% during the first quarter. Vestmark Advisory Solutions Inc. now owns 21,946 shares of the company’s stock worth $526,000 after acquiring an additional 11,950 shares in the last quarter. Neuberger Berman Group LLC lifted its stake in Kenvue by 252.7% in the first quarter. Neuberger Berman Group LLC now owns 936,264 shares of the company’s stock valued at $22,452,000 after acquiring an additional 670,791 shares during the last quarter. Finally, Boston Partners grew its position in shares of Kenvue by 7.4% in the 1st quarter. Boston Partners now owns 25,346,453 shares of the company’s stock valued at $606,920,000 after acquiring an additional 1,750,490 shares during the period. Institutional investors and hedge funds own 97.64% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on KVUE. Bank of America dropped their target price on shares of Kenvue from $27.00 to $25.00 and set a “buy” rating on the stock in a report on Tuesday, July 15th. JPMorgan Chase & Co. dropped their price objective on Kenvue from $27.00 to $26.00 and set an “overweight” rating on the stock in a research note on Friday, July 25th. Royal Bank Of Canada reduced their target price on Kenvue from $24.00 to $22.00 and set a “sector perform” rating for the company in a research note on Friday, August 8th. Barclays decreased their target price on Kenvue from $23.00 to $22.00 and set an “equal weight” rating on the stock in a report on Tuesday, July 15th. Finally, Canaccord Genuity Group reduced their price objective on shares of Kenvue from $29.00 to $26.00 and set a “buy” rating for the company in a research report on Friday, August 8th. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and five have issued a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $24.38.

Kenvue Stock Up 0.4%

KVUE opened at $21.15 on Monday. The stock has a fifty day moving average of $21.54 and a 200-day moving average of $22.43. The company has a market capitalization of $40.59 billion, a P/E ratio of 28.58, a P/E/G ratio of 3.05 and a beta of 0.83. Kenvue Inc. has a fifty-two week low of $19.75 and a fifty-two week high of $25.17. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.68 and a current ratio of 0.98.

Kenvue (NYSE:KVUE) last released its quarterly earnings results on Thursday, August 7th. The company reported $0.29 EPS for the quarter, topping analysts’ consensus estimates of $0.28 by $0.01. The business had revenue of $3.84 billion for the quarter, compared to analyst estimates of $3.94 billion. Kenvue had a net margin of 9.37% and a return on equity of 20.06%. Kenvue’s revenue for the quarter was down 4.0% compared to the same quarter last year. During the same period last year, the firm earned $0.32 earnings per share. On average, equities analysts expect that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, August 27th. Investors of record on Wednesday, August 13th will be paid a $0.2075 dividend. This represents a $0.83 annualized dividend and a dividend yield of 3.9%. This is an increase from Kenvue’s previous quarterly dividend of $0.21. The ex-dividend date is Wednesday, August 13th. Kenvue’s dividend payout ratio is presently 112.16%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.